Analysis of Genotoxic Impurities

Article

Researchers from the Research Institute for Chromatography (Kortrijk, Belgium) and AstraZeneca R&D Charnwood (Loughborough, UK) used in-situ derivatization and liquid chromatography?mass spectrometry (LC?MS) to analyze arylamines and aminopyridines, which can be present as potentially genotoxic impurities in pharmaceutical preparations at trace levels.

Researchers from the Research Institute for Chromatography (Kortrijk, Belgium) and AstraZeneca R&D Charnwood (Loughborough, UK) used in-situ derivatization and liquid chromatography–mass spectrometry (LC–MS) to analyze arylamines and aminopyridines, which can be present as potentially genotoxic impurities in pharmaceutical preparations at trace levels. The method included a derivatization procedure using hexylchloroformate followed by reversed-phase LC with single-quadrupole MS in the selected ion monitoring mode. They found that the derivatized compounds exhibited better chromatographic behavior.

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Recent Videos
Bob Pirok
Caroline West © Image courtesy of interviewee
Gesa Schad © Image courtesy of interviewee
Image Credit: Josephine Ouma
Image Credit: Josephine Ouma
Image Credit: Josephine Ouma
Related Content